Top

Current Bladder Dysfunction Reports

Published in:

Open Access 01-06-2019 | Cystitis | Inflammatory/Infectious Bladder Disorders (MS Mourad, Section Editor)

The Inflammatory Contracted Bladder

Authors: Hector Cantu, Siti Nur Masyithah Maarof, Hashim Hashim

Published in: Current Bladder Dysfunction Reports | Issue 2/2019

Abstract

Purpose of Review

This review will present the inflammatory contracted bladder as a clinical entity and will address its pathophysiology, diagnosis and treatment.

Recent Findings

The inflammatory contracted bladder is relevant since it is not a recognised urological condition and it can be found in several affections to the urinary tract. Its medical management depends on its aetiology and severity.

Summary

The inflammatory contracted bladder (ICB) is an ambiguous term that is used to describe the morphology of the inflamed bladder with a reduced volumetric capacity and compliance. This condition is found in some urological pathologies such as bladder outlet obstruction, infections, drug toxicity, radiation cystitis and other inflammatory diseases like interstitial cystitis, malacoplakia and eosinophilic cystitis. This entity is usually presented at the end stage of disease and represents an irreversible damage to the urinary tract.

Leçons cliniques sur les maladies des voies urinaires : sémiologie, diagnostic, pathologie et thérapeutique générales : professées à l'hôpital Necker. Symptômes fonctionnels, modifications pathologiques des urines / par J.-C.-Félix Guyon,... Gallica. https://gallica.bnf.fr/ark:/12148/bpt6k5663156r/f6.image.texteImage. Accessed 6 Nov 2018.

Krotoszyner M. The Cystoscopic diagnosis of contracted bladder. J Am Med Assoc. 1917;LXVIII(9):687. https://doi.org/10.1001/jama.1917.04270030019006.CrossRef

•• Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence society. Neurourol Urodyn. 2002;21(2):167–78. https://doi.org/10.1002/nau.10052 Describes the terminology of the urinary tract. CrossRef

Lee Y, Lin K, Chuang S, et al. Elucidating mechanisms of bladder repair after hyaluronan instillation in ketamine-induced ulcerative cystitis in animal model. Am J Pathol. 2017;187(9):1945–59. https://doi.org/10.1016/j.ajpath.2017.06.004.CrossRefPubMed

• Fry C. Ics.org. https://www.ics.org/Publications/ICI_3/v1.pdf/chap6.pdf. Published 2018. Accessed 6 Nov 2018. Highlights the cellular mechanism of the urinary tract.

Kaplan E, Richier J, Howard P, Ewalt D, Lin V. Type III collagen messenger RNA is modulated in non-compliant human bladder tissue. J Urol. 1997;157(6):2366–9. https://doi.org/10.1016/s0022-5347(01)64782-7.CrossRefPubMed

Djavan B, Lin V, Kaplan E, et al. Decreased elastin gene expression in noncompliant human bladder tissue: a competitive reverse transcriptase-polymerase chain reaction analysis. J Urol. 1998;160(5):1658–62. https://doi.org/10.1016/s0022-5347(01)62375-9.CrossRefPubMed

Zhang E, Stein R, Chang S, et al. Smooth muscle hypertrophy following partial bladder outlet obstruction is associated with overexpression of non-muscle Caldesmon. Am J Pathol. 2004;164(2):601–12. https://doi.org/10.1016/s0002-9440(10)63149-5.CrossRefPubMedPubMedCentral

Dmochowski RR. Bladder outlet obstruction: etiology and evaluation. Rev Urol. 2005;7(Suppl 6):S3–S13.PubMedPubMedCentral

10.

Madersbacher S, Pycha A, Schatzl G, Mian C, Klingler C, Marberger M. The aging lower urinary tract: a comparative urodynamic study of men and women. Urology. 1998;51(2):206–12. https://doi.org/10.1016/s0090-4295(97)00616-x.CrossRefPubMed

11.

Pfisterer M, Griffiths D, Schaefer W, Resnick N. The effect of age on lower urinary tract function: a study in women. J Am Geriatr Soc. 2006;54(3):405–12. https://doi.org/10.1111/j.1532-5415.2005.00613.x.CrossRefPubMed

12.

Rakesh K, Ansari MS, Anil M, Anil G. Clinical presentation and diagnostic approach in cases of genitourinary tuberculosis. Indian J Urol. 2008;24(3):401–5.CrossRef

13.

Zarrabi AD, Heyns CF. Clinical features of confirmed versus suspected urogenital tuberculosis in region with extremely high prevalence of pulmonary tuberculosis. Urology. 2009;74(1):41–5.CrossRefPubMed

14.

Kao SC, Fang JT, Tsai CJ, Chen KS, Huang CC. Urinary tract tuberculosis: a 10-year experience. Changgeng Yi Xue Za Zhi. 1996;19(1):1–9.PubMed

15.

Kulchavenya E. Best practice in the diagnosis and management of urogenital tuberculosis. Ther Adv Urol. 2013;5(3):143–51.CrossRefPubMedPubMedCentral

16.

Ross AG, Bartley PB, Sleigh AC, Olds GR, Li Y, Williams GM, et al. Schistosomiasis. N Engl J Med. 2002;346(16):1212–20.CrossRefPubMed

17.

Gryseels B, Polman K, Clerinx J, Kestens L. Human schistosomiaisis. Lancet. 2006;368(9541):1106–18.CrossRefPubMed

18.

Winstock AR, Mitcheson L, Gillatt DA, Cottrell AM. The prevalence and natural history of urinary symptoms among recreational ketamine users. BJU Int. 2012;110:1762–6.CrossRefPubMed

19.

Middela S, Pearce I. Ketamine-induced vesicopathy: a literature review. Int J Clin Pract. 2011;65(1):27–30.CrossRefPubMed

20.

Chu PS, Ma WK, Wong SC, Chu RW, Cheng CH, Wong S, et al. The destruction of the lower urinary tract by ketamine abuse: a new syndrome? BJU Int. 2008;102(11):1616–22.CrossRefPubMed

21.

Tsai TH, Cha TL, Lin CM, Tsao CW, Tang SH, Chuang FP, et al. Ketamine-associated bladder dysfunction. Int J Urol. 2009;16(10):826–9.CrossRefPubMed

22.

Tanagho E. Congenitally obstructed bladders: fate after prolonged defunctionalization. J Urol. 1974;111(1):102–9. https://doi.org/10.1016/s0022-5347(17)59900-0.CrossRefPubMed

23.

Nagatomi J, DeMiguel F, Torimoto K, Chancellor M, Getzenberg R, Sacks M. Early molecular-level changes in rat bladder wall tissue following spinal cord injury. Biochem Biophys Res Commun. 2005;334(4):1159–64. https://doi.org/10.1016/j.bbrc.2005.07.011.CrossRefPubMed

24.

Singh O, Gupta S, Arvind N. A case of extensive genitourinary tuberculosis: combined augmentation ileo-cystoplasty, ureteric ileal replacement and buccal mucosal graft urethroplasty. Updat Surg. 2012;65(3):245–8. https://doi.org/10.1007/s13304-012-0141-8.CrossRef

25.

Wong-You–Cheong J, Woodward P, Manning M, Davis C. Inflammatory and nonneoplastic bladder masses: radiologic-pathologic correlation. RadioGraphics. 2006;26(6):1847–68. https://doi.org/10.1148/rg.266065126.CrossRefPubMed

26.

Awad S, MacDiarmid S, Gajewski J, Gupta R. Idiopathic reduced bladder storage versus interstitial cystitis. J Urol. 1992;148(5):1409–12. https://doi.org/10.1016/s0022-5347(17)36923-9.CrossRefPubMed

27.

Fall M, Johansson S, Aldenborg F. Chronic interstitial cystitis: a heterogeneous syndrome. J Urol. 1987;137(1):35–8. https://doi.org/10.1016/s0022-5347(17)43863-8.CrossRefPubMed

28.

Wein A, Kavoussi L, Partin A, Peters C, Campbell M. Campbell-Walsh Urology. 11th ed. Amsterdam: Elsevier; 2016. p. 289.

29.

Dasgupta P, Womack C, Turner A. Malacoplakia: Von Hansemann’s disease. BJU Int. 1999;84:464–9.CrossRefPubMed

30.

Huan D, Sarah D, Joe P, Shalini C, Kesavapilla S. Malacoplakia of the urogenital tract. Urol Case Rep. 2015;3(1):6–8. https://doi.org/10.1016/j.eucr.2014.10.002.CrossRef

31.

Vail J. Innovative uses of compound tranilast: an interview with compounding pharmacist Larry J. Frieders, RPh. Int J Pharm Compd. 2007;11(2):130–3.PubMed

32.

Okada H, Minayoshi K, Goto A. Two cases of eosinophilic cystitis induced by tranilast. J Urol. 1992;147(5):1366–8.CrossRefPubMed

33.

Sakai N, Yamada T, Murayama T. Eosinophilic cystitis induced by tranilast: a case report. Hinyokika Kiyo. 1998;44(1):45–7.PubMed

34.

Teegavarapu P, Sahai A, Chandra A, Dasgupta P, Khan M. Eosinophilic cystitis and its management. Int J Clin Pract. 2005;59(3):356–60. https://doi.org/10.1111/j.1742-1241.2004.00421.x.CrossRefPubMed

35.

Middela S, Pearce I. Ketamine-induced vesicopathy: a literature review. Int J Clin Pract. 2010;65(1):27–30. https://doi.org/10.1111/j.1742-1241.2010.02502.x.CrossRef

36.

Srirangam S, Mercer J. Ketamine bladder syndrome: an important differential diagnosis when assessing a patient with persistent lower urinary tract symptoms. BMJ Case Rep. 2012;2012. https://doi.org/10.1136/bcr-2012-006447.

37.

O'Donnell M. Practical applications of Intravesical chemotherapy and immunotherapy in high-risk patients with superficial bladder cancer. Urol Clin N Am. 2005;32(2):121–31. https://doi.org/10.1016/j.ucl.2005.01.003.CrossRef

38.

Witjes J, Palou J, Soloway M, et al. Clinical practice recommendations for the prevention and management of intravesical therapy–associated adverse events. Eur Urol Suppl. 2008;7(10):667–74. https://doi.org/10.1016/j.eursup.2008.08.001.CrossRef

39.

Wajsman Z, McGill W, Englander L, Huben R, Pontes J. Severely contracted bladder following intravesical mitomycin C therapy. J Urol. 1983;130(2):340–1. https://doi.org/10.1016/s0022-5347(17)51139-8.CrossRefPubMed

40.

Arakawa M, Nakamura K, Yamada Y, Rosser CJ, Tobiume M, Saito H, et al. Association between gefitinib and hemorrhagic cystitis and severely contracted bladder: a case report. BMC Urol. 2010;10(1). https://doi.org/10.1186/1471-2490-10-6.

41.

Vale J, Bowsher W, Liu K, Tomlinson A, Whitfield H, Trott K. Post-irradiation bladder dysfunction: development of a rat model. Urol Res. 1993;21(6):383–8. https://doi.org/10.1007/bf00300073.CrossRefPubMed

42.

Huang W, Yang J. Sonographic findings in a case of postradiation hemorrhagic cystitis resolved by hyperbaric oxygen therapy. J Ultrasound Med. 2003;22(9):967–71. https://doi.org/10.7863/jum.2003.22.9.967.CrossRefPubMed

43.

Kristiansen P, Pompeius R, Wadström L. Long-term urethral catheter drainage and bladder capacity. Neurourol Urodyn. 1983;2(2):135–43. https://doi.org/10.1002/nau.1930020207.CrossRef

44.

Virdi G, Hendry D. Urinary retention: catheter drainage bag or catheter valve? Curr Urol. 2015;9(1):28–30. https://doi.org/10.1159/000442847.CrossRef

45.

Morelli A, Comeglio P, Filippi S, Sarchielli E, Cellai I, Vignozzi L, et al. Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome. J Steroid Biochem Mol Biol. 2012;132(1–2):80–92. https://doi.org/10.1016/j.jsbmb.2012.02.007.CrossRefPubMed

46.

Chen J, Lee M, Kuo H. Reduction of cystometric bladder capacity and bladder compliance with time in patients with end-stage renal disease. J Formos Med Assoc. 2012;111(4):209–13. https://doi.org/10.1016/j.jfma.2011.09.023.CrossRefPubMed

47.

Minervini R, Morelli G, Minervini A, Pampaloni S, Tognetti A, Fiorentini L, et al. Bladder involvement in systemic sclerosis: urodynamic and histological evaluation in 23 patients. Eur Urol. 1998;34(1):47–52. https://doi.org/10.1159/000019678.CrossRefPubMed

Title: The Inflammatory Contracted Bladder
Authors: Hector Cantu
Siti Nur Masyithah Maarof
Hashim Hashim
Publication date: 01-06-2019
Publisher: Springer US
Keywords: Cystitis
Cystitis
Published in: Current Bladder Dysfunction Reports / Issue 2/2019
Print ISSN: 1931-7212
Electronic ISSN: 1931-7220
DOI: https://doi.org/10.1007/s11884-019-00507-w

ACC 2024 Congress

Springer Medicine

The Inflammatory Contracted Bladder

Abstract

Purpose of Review

Recent Findings

Summary

ACC 2024 Congress

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 2/2019

Urethral Pain Syndrome: A Systematic Review

Effects and Complications of Intravesical Instillation of Bacillus Calmette-Guerin Therapy

Mathematical Modeling and Uroflow-Based Nomograms in Voiding Dysfunction Evaluation: Ready for Prime Time?

New Diagnostics for Male Lower Urinary Tract Symptoms

The Effect of Major Pelvic Extirpative Surgery on Lower Urinary Tract Function

The Current Role of Botox in a Pediatric Neurogenic Bladder Condition